Macrogenics MGNX
NASDAQ MGNX
$3.60 -0.26 (-6.74%)
At close: Oct 1, 2026 · 4:00 PM EDT

Macrogenics (MGNX) Return on Equity [ROE] (2013 - 2026)

Updated

Macrogenics' Return on Equity [ROE] was -50.31% in Q2 2026, up 10.25 percentage points from -60.57% a year earlier and up 136.91 percentage points from the prior quarter.

Analysis

Macrogenics (MGNX) Return on Equity [ROE] (2013 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Macrogenics came in at -86.91%, down 37.06 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of -37.13 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -49.85% in FY2024 (-43.70 pp), -6.15% in FY2023 (+56.61 pp), -62.76% in FY2022 (+12.98 pp) and -75.74% in FY2021 (-25.96 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q3 2021.
  • Compared with a year earlier, Return on Equity [ROE] was higher in four of the last eight quarters, with an average year-over-year change of +5.05 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2025 (a gain of 177.77 percentage points); the worst was Q2 2024 (a drop of 168.69 percentage points).
  • Per Business Quant data, MGNX's Return on Equity [ROE] in the three quarters before Q2 2026 was -187.22% (Q1 2026), -124.43% (Q4 2025) and -136.54% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Macrogenics 245.67 Mn -72.10 Mn - -50.31%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -50.31%
Mar 31, 2026 -187.22%
Dec 31, 2025 -124.43%
Sep 30, 2025 -136.54%
Jun 30, 2025 -60.57%
Mar 31, 2025 -58.91%
Dec 31, 2024 -59.00%
Sep 30, 2024 -116.47%
Jun 30, 2024 -238.34%
Mar 31, 2024 -143.35%
Dec 31, 2023 -97.91%
Sep 30, 2023 -59.28%
Jun 30, 2023 -69.65%
Mar 31, 2023 -74.71%
Dec 31, 2022 -91.65%
Sep 30, 2022 -144.39%
Jun 30, 2022 -137.00%
Mar 31, 2022 -104.42%
Dec 31, 2021 -76.37%
Sep 30, 2021 -48.07%
API Access

Macrogenics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MGNX&period=max&api_key=YOUR_API_KEY